Skip to content

Clinical trials

Phase 2 Pulmonary Disease, Chronic Obstructive trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 2 Country / region: Germany Clear all

93 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20066
200713
200811
20096
201011
20112
20123
20134
20146
20153
20163
20174
20183
20194
20203
20211
20223
20231
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed81
Terminated7
Active, not recruiting2
Recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline28
AstraZeneca17
Boehringer Ingelheim10
Novartis Pharmaceuticals7
Novartis5
Chiesi Farmaceutici S.p.A.4
Pfizer4
Janssen Research & Development, LLC2
Revotar Biopharmaceuticals AG2
Sanofi2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive93
Bronchitis, Chronic8
Asthma7
Emphysema6
Respiration Disorders5
Lung Diseases4
Bronchiolitis Obliterans Syndrome2
Inflammation2
Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome1
Cachexia1

Trials

Showing 1 to 25 of 93. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.